GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ningxia Zhongke Biotechnology Co Ltd (SHSE:600165) » Definitions » Cyclically Adjusted Price-to-FCF

Ningxia Zhongke Biotechnology Co (SHSE:600165) Cyclically Adjusted Price-to-FCF : (As of May. 28, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Ningxia Zhongke Biotechnology Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Ningxia Zhongke Biotechnology Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Ningxia Zhongke Biotechnology Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ningxia Zhongke Biotechnology Co Cyclically Adjusted Price-to-FCF Chart

Ningxia Zhongke Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ningxia Zhongke Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ningxia Zhongke Biotechnology Co's Cyclically Adjusted Price-to-FCF

For the Specialty Chemicals subindustry, Ningxia Zhongke Biotechnology Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ningxia Zhongke Biotechnology Co's Cyclically Adjusted Price-to-FCF Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Ningxia Zhongke Biotechnology Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Ningxia Zhongke Biotechnology Co's Cyclically Adjusted Price-to-FCF falls into.



Ningxia Zhongke Biotechnology Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Ningxia Zhongke Biotechnology Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Ningxia Zhongke Biotechnology Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.002/115.2271*115.2271
=-0.002

Current CPI (Mar. 2024) = 115.2271.

Ningxia Zhongke Biotechnology Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.011 98.200 0.013
201409 0.025 98.900 0.029
201412 -1.102 99.000 -1.283
201503 0.542 99.900 0.625
201506 -0.101 99.500 -0.117
201509 0.142 100.500 0.163
201512 -0.622 100.600 -0.712
201603 -0.053 102.200 -0.060
201606 -0.024 101.400 -0.027
201609 0.260 102.400 0.293
201612 -0.471 102.600 -0.529
201703 0.005 103.200 0.006
201706 -0.093 103.100 -0.104
201709 0.644 104.100 0.713
201712 -0.534 104.500 -0.589
201803 -0.056 105.300 -0.061
201806 -0.136 104.900 -0.149
201809 -0.080 106.600 -0.086
201812 -0.066 106.500 -0.071
201903 -0.149 107.700 -0.159
201906 -0.030 107.700 -0.032
201909 -0.133 109.800 -0.140
201912 -0.499 111.200 -0.517
202003 -0.148 112.300 -0.152
202006 -0.566 110.400 -0.591
202009 -0.234 111.700 -0.241
202012 -0.257 111.500 -0.266
202103 -0.165 112.662 -0.169
202106 -0.158 111.769 -0.163
202109 -0.017 112.215 -0.017
202112 -0.038 113.108 -0.039
202203 -0.142 114.335 -0.143
202206 0.083 114.558 0.083
202209 0.089 115.339 0.089
202212 -0.045 115.116 -0.045
202303 -0.063 115.116 -0.063
202306 0.006 114.558 0.006
202309 -0.010 115.339 -0.010
202312 0.016 114.781 0.016
202403 -0.002 115.227 -0.002

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ningxia Zhongke Biotechnology Co  (SHSE:600165) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Ningxia Zhongke Biotechnology Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Ningxia Zhongke Biotechnology Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Ningxia Zhongke Biotechnology Co (SHSE:600165) Business Description

Traded in Other Exchanges
N/A
Address
Hebin Street, Ningxia Hui Autonomous Region, Huinong District, Shizuishan, CHN, 750002
Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.
Executives
Huang Hai Su Director
Chen Jin Song senior management
Li Li Shan Director
Ma Xiao Qiu Supervisors

Ningxia Zhongke Biotechnology Co (SHSE:600165) Headlines

No Headlines